Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Mid Cap | Pharmaceuticals & Drugs
1461.00
-0.55
(-0.04%)
< Home
< Back
Cipla Ltd. News
>>
Cipla inks pact with ImmunoACT to commercialize talicabtagene autoleucel in Africa
>>
Cipla launches orally inhaled insulin in India
>>
Cipla informs about updates
>>
Cipla moves up on launching ‘Yurpeak’
>>
Cipla launches ‘Yurpeak’
>>
Cipla gains on completing acquisition of 100% stake in Inzpera Healthsciences
>>
Cipla completes acquisition of 100% stake in Inzpera Healthsciences
>>
Cipla gains on launching therapy for Knee Osteoarthritis ‘Ciplostem’
>>
Cipla launches therapy for Knee Osteoarthritis ‘Ciplostem’
>>
Cipla launches integrated lung diagnostics, wellness centre in Delhi
<<
<
3
4
5
...104
>
>>